Navigation Links
Strativa Pharmaceuticals Provides Product Pipeline Update
Date:4/9/2009

Files NDA for Ondansetron Orally Dissolving Film Strip

BioAlliance to Resubmit Loramyc(R) NDA

WOODCLIFF LAKE, N.J., April 9 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX), today provides an update on two of its pipeline products.

Ondansetron Orally Dissolving Film Strip

On April 7, 2009, Strativa submitted a New Drug Application (NDA) for its new orally dissolving film strips (ODFS) formulation of ondansetron to the U.S. Food and Drug Administration (FDA). Strativa is seeking approval of ondansetron ODFS in 8 mg and 4 mg strengths for the prevention of chemotherapy and radiation-induced nausea and vomiting, and prevention of post-operative nausea and vomiting.

A program consisting of three separate pivotal studies comparing the bioequivalence of ondansetron ODFS 8mg to Zofran ODT(R) 8mg was completed in December 2008 and supports the NDA filing of ondansetron ODFS. The pharmacokinetic results of each study demonstrate that a single dose of ondansetron ODFS, taken with or without water, is bioequivalent to Zofran ODT, taken under similar conditions.

The antiemetic market totaled 4.1 million prescriptions in 2008. Ondansetron was the prescription leader in the category, accounting for 95% of prescriptions.

In June 2008, Strativa acquired the commercialization rights in the United States and its territories to ondansetron ODFS from MonoSol Rx. To date, Strativa has paid MonoSol Rx a total of $3.5 million for the completion of certain milestones.

Loramyc(R) (miconazole Lauriad) for the treatment of oropharyngeal candidiasis (OPC)

After preliminary review, the FDA h
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
2. Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... STOUGHTON, Mass. , Feb. 9 STD ... in Stoughton, Massachusetts is pleased to announce the ... West Bridgewater, Massachusetts . This is in addition to the ... be growing and advancing the company during these difficult financial ... attribute this growth to the premise on which STD Med ...
(Date:2/9/2010)... LIVESTRONG Quarterly is ... STRONG .  The magazine features profiles of survivors and ... about cancer prevention and treatment; and general articles about ... cancer survivor, I understand the worries and concerns other ... President and CEO Doug Ulman .  "Our ...
(Date:2/9/2010)... Feb. 9 Reportlinker.com ... is available in its catalogue: ,, ... Market Forecasts to 2016 ,, ... Pipeline Analysis and Market Forecasts to 2016 ... industry analysis specialist,s new report, "Atrial Fibrillation ...
Breaking Medicine Technology:STD Med Inc. Acquires Facility for Manufacturing and Start-Ups 2SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 2SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 3SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 4Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016 2Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016 3Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016 4Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016 5Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016 6Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016 7Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016 8Involving family in medical rounds benefits both family and medical team 62042 1Involving family in medical rounds benefits both family and medical team 62042 2Involving family in medical rounds benefits both family and medical team 62042 3Involving family in medical rounds benefits both family and medical team 62042 4Rocket science leads to new whale discovery 10893 1Rocket science leads to new whale discovery 10893 2Springer and the American College of Medical Toxicology to work together 10889 1Springer and the American College of Medical Toxicology to work together 10889 2
... The Netherlands, January 13 ProFibrix B.V., today,announced ... with Crucell,N.V. (Euronext, NASDAQ: CRXL ; ... production platform. The PER.C6(R) platform allows ProFibrix to,manufacture ... and commercial roll-out of new products. Fibrinogen is ...
... 12 American Life League,s historic Personhood ... in adult stem cell research and regenerative ... Deisher, founder and CEO of AVM Biotechnology ... is speaking on over 17 years of ...
Other Medicine Technology:ProFibrix Steps up Recombinant Fibrinogen Program With PER.C6(R) License From Crucell 2Stem Cell Pioneer to Speak to A.L.L. Personhood Conference 2
(Date:2/9/2010)... WORTH, Texas , Feb. 9 ... professor and project coordinator for the University of ... UNT Health Science Center , was instrumental in recently ... buried in the Patio 29 cemetery. ,, The ... the lead geneticist for a process audit team of ...
(Date:2/9/2010)... Freedom Act Could See Idaho Lose $1.6 Billion ... Idaho , Feb. 9 As the ... a non-existent federal health care law, the long-term effects of ... is calling the Idaho Health Freedom Act (House Bill 391) ... into law, could see Idaho lose nearly ...
(Date:2/9/2010)... 8, 2010- The research group of Dr. Franois Robert, ... Montral (IRCM), in collaboration with the team of Dr. ... Toronto) accomplished a technical breakthrough: they mapped all the ... Saccharomyces cerevisiae . The method used by the ... been published online today in the scientific journal ...
(Date:2/9/2010)... most comprehensive study to date of secondhand smoke exposure ... journal Addiction . The study, carried out by ... reveals that exposure to household secondhand smoke among children ... researchers wanted to find out if there were ways ... children in private households, and whether those levels were ...
(Date:2/9/2010)... State University has launched the nation,s first comprehensive ... counterfeiting- which the FBI has called "the crime ... products- from pharmaceuticals to food additives to auto ... in global trade and has a major impact ... and national security. Terrorist and other organized crime ...
Breaking Medicine News(10 mins):Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 2Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 3Health News:Idaho House Moves State Closer to Health Care Disaster 2Health News:Idaho House Moves State Closer to Health Care Disaster 3Health News:Idaho House Moves State Closer to Health Care Disaster 4Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 2Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 3Health News:Exposure to secondhand smoke among children in England has declined since 1996 2Health News:MSU launches first anti-counterfeiting research program 2Health News:MSU launches first anti-counterfeiting research program 3
... LOS ANGELES, April 30 , WHAT: Californians for Patient Care (CPC) ... discuss free healthcare resources available to Californians, how ... million patients statewide as well ... a daily basis, media outlets report on the economic uncertainty ...
... CHERRY HILL, N.J., April 30 T.J. Harkins, ... abstract related to,erectile dysfunction product, TriMix-gel(TM), will be ... Association (AUA) annual,meeting, May 20, 2008 in Orlando, ... IN MEN WHO FAILED PHOSPHODIESTERASE INHIBITORS., The ...
... NEW ROCHELLE, N.Y., April 30 Jeffrey,Laurence, M.D., ... and STDs ( http://www.liebertpub.com/apc ), and the journal,s,publisher, ... Obama to set,the record straight about the AIDS ... attempt by the United States government to wipe ...
... ALTO, Calif., April 30 Preterm birth, healthy,eating and ... discussed by,Lucile Packard Children,s Hospital physicians at the upcoming ... just a few,summaries of planned presentations. For more information ... at (650) 387-7500 or email,rdicks@lpch.org., **ALL RESEARCH ...
... In small study, device helped a little more than ... 30 (HealthDay News) -- Another successful clinical trial suggests ... people with acute renal failure will be available within ... short-term replacement of renal cell function using the renal ...
... lower womens risk of a particular type of breast ... access journal Breast Cancer Research. In this large study, ... estrogen receptor-positive breast cancers. However, unlike in some previous ... reduce the total risk of breast cancer. , ...
Other Medicine News:Health News:TriMix-gel vs Viagra, Levitra, Cialis Data to Be Presented at AUA 2Health News:OPEN LETTER: Medical Journal Calls Upon Barack Obama to Set the Record Straight on AIDS Virus 2Health News:New Research From Packard Children's Hospital Experts Presented at 2008 Pediatric Academic Societies' Annual Meeting 2Health News:New Research From Packard Children's Hospital Experts Presented at 2008 Pediatric Academic Societies' Annual Meeting 3Health News:New Research From Packard Children's Hospital Experts Presented at 2008 Pediatric Academic Societies' Annual Meeting 4Health News:Bioartificial Kidney Cuts Death Risk, Improves Outcomes 2Health News:Daily aspirin may reduce risk of common type of breast cancer 2
... Circulatory Support System consists of two principal components. ... that drives the blood pumps and can be ... of patients between hospitals. The AB5000 Ventricle is ... left, right, or both ventricles of the heart ...
... virus belongs to the Flavavirus group pf ... the tropics.,Symptoms of Dengue fever are the ... the back and limbs, lymphadenopathy,maculopapular rash and ... use as an aid in the diagnosis ...
... the intracellular parasite Toxoplasma gondii and,may be ... contract with cat,feces containing oocytes. If a ... to the fetus through the placenta. This ... cause of mortality and malformation.,This test is ...
Inquire...
Medicine Products: